November 2020

Despite the re-scheduling of cannabis-based medicines almost 2-years ago in the UK, patient access to medical cannabis remains extremely limited with only a few hundred scripts issued to date, predominantly within the private medical sector.   A lack of understanding of the endocannabinoid system (ECS) and...